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 To better bridge research with commercialization, this project sought to develop 
an improved analytical method for the assay of biosurfactants known as surfactins from 
Bacillus subtilis.  We sought to compare levels of production from various strains of B. 
subtilis, including strain 203R, which was isolated from areas prone to oil degraders.  The 
use of Ultra-Performance Liquid Chromatography coupled with High Resolution Mass 
Spectrometry proved beneficial for the selective identification and quantification of 
surfactin lipopeptides.  Surfactins were eluted in under 10 minutes and quantified using 
the total area of generated ions.  Near baseline separation across the envelope gave an 
added layer of identification to the ions responsible for surfactins.  These lipopeptides, 
having similar molecular masses to the iturins, nearly coelute complicating the analysis.  
By coupling retention time with fragmentation pattern, some isoforms could be 
distinguished.  Validation of the method was achieved by obtaining 4 calibration curves 
on different days and applying linear regression analysis.  Strain 203R was shown to be a 
superior producer of surfactins than the previously reported model strain ATCC 21332.      
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CHAPTER I  
INTRODUCTION 
 
A wide range of synthetic surfactants have been created with properties of 
detergency and emulsification that are unparalleled.  While these chemicals possess 
proven performance in many areas, they are unsuitable for use in some pharmaceutical 
and medical applications.  Biosurfactants from microorganisms show continued interest 
as renewable or green alternatives to petroleum based surfactants.  One of the most 
powerful biosurfactant classes known, the surfactins, have shown use in oil recovery, 
bioremediation and as emulsifiers in cosmetic formulations (Fracchia et al., 2012).   
Their use as excipients in formulations allows alterations in solubility and 
absorption of pharmaceuticals, and can also provide dissolution and lubricity.  
Surfactants are also used to alter the flowability of fine particle granular formulations.  In 
the case of bronchodilation, Symbicort® (Astra-Zeneca) utilizes a two component 
bronchodilator system to give extended efficacy to the patient.  For particles to reach the 
bronchioles, they must be small enough and smooth enough to travel in the air to their 
target receptors on smooth muscle (Lewis and Copley, 2011).  Polyethylene glycol (PEG) 
1000 and magnesium stearate are two such preferred surfactants providing the flowability 
and lubricity necessary for bronchodilator formulations (Astra Zeneca, US 8,461,211 
B2).  One of the most well documented examples of naturally produced surfactants is the 
action of pulmonary biosurfactant to effect transfer of oxygen in the alveoli.  These 
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biosurfactants lower the surface tension of the thin aqueous layer in the alveolar lumen to 
facilitate transfer of oxygen to its eventual heme destination (Silverthorn et al., 2009).   
 The lipopeptides comprising surfactin are unique among biosurfactants in that 
they have pronounced ability to lower surface tension in water from 72 to 27 dynes at 20 
μmol/L (Chen et al., 2008).  They are likely the most prominent antibiotic produced 
within the Bacillus genus and have been much studied for their antibacterial, 
antimycoplasma (Vollenbroich et al. 1997), antitumor (Lim et al. 2005), insecticidal and 
even antiviral properties (Das, K. et al. 2006, Vater et al. 2002).   The hydrophobic chain 
moiety of the surfactins is unique since it is incorporated by the non-ribosomal peptide 
synthetases (NRPS) (Stein et al., 2005).  Three genes are required for the biosynthesis of 
surfactins: srfA-A, srfA-B and srfA-C, which in total comprise the srfA operon.  The final 
step to form the macrolactone occurs via the terminal Te domain of srfA-C (Sonenshein 
et al., 2002). This biosynthesis of antibiotics is not uncommon to bacteria and fungi.  
 B. subtilis strains produce a wide spectrum of antibiotics and while no single 
strain possesses all the genes, the antibiotics can be divided into three main classes: the 
lantibiotics, lipopeptide antibiotics and small hydrophilic antifungal peptides.  The 
lantibiotics contain crosslinked structures having disulfide bond(s) which can be the site 
of antibacterial activity via reduction (Stein et al., 2005; Van der Molen et al., 2011).  
Lipopeptide antibiotics are amphiphilic and often cyclic structures which are membrane 
active.  These compounds comprise the surfactins, iturins, fengycins, mycosubtilin and 
bacillomycin.  Examples of small hydrophilic antifungal peptides are bacilysin and  
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rhizocticins (Stein et al., 2005, Leenders, 1999).  Table 1 below summarizes the 
 
structures of all known B. subtilis antibiotics and their genetic biosynthesis. 
 
 
Table 1.  Summary of B. subtilis Antibiotics.   
Stein, T. Molecular Microbiology (2005) 56(4), 849.  Reproduced with permission, John Wiley 
and Sons and Copyright Clearance Center, April 26, 2018. 
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Traditionally, the ATCC 21332 strain of Bacillus subtilis has been used as the 
model producer of surfactins (Mohammadipour et al., 2009). The discovery of another 
strain, 203R described herein, has shown to yield increased amounts of lipopeptides. 
These lipopeptides and other antibiotics having surface activity can be enriched from 
batch fermentation systems through a process known as foam fractionation, acid 
precipitation or a combination of both (Chen, et al., 2008).  To bridge research with 
commercialization, we sought to develop an improved analytical method for the assay of 
surfactins using Ultra Performance Liquid Chromatography (UPLC) coupled to 
Electrospray Ionization Mass Spectrometry (ESI-MS) with a LTQ Mass Spectrometer 
utilizing Orbitrap Technology.  The goal of this work was to develop and validate the 
new method of surfactin analysis, and to apply it to compare quantity of surfactin 
produced by several strains of B. subtilis. 
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CHAPTER II  
BIOSYNTHESIS 
 
 
NRPS Assembly 
 
Secondary metabolite production in fungi, bacteria and plants utilizes a different 
pathway for the incorporation of amino acids.  In these instances, the central dogma gives 
way to processes largely independent of mRNA.  These secondary metabolites are built 
using large multienzyme complexes such as the polyketide synthases (PKS) or 
nonribosomal peptide synthetase (NRPS) systems.  The range of nonproteinogenic amino 
acids used extends well beyond the canonical essential and nonessential ones.  For this 
reason, they are often referred to as monomers for the NRPS modules.  The primary 
structure of these peptidyl regions is short, from two to about fifty monomers, rarely 
linear and can contain branchings and cycles (Grünewald and Marahiel, 2013).   
Contained within this NRPS complex are repeating domains of condensation, 
adenylation, thiolation, epimerization, termination and cyclization.  Repeating domains 
which give one complete elongation cycle can be grouped and give rise to modules 
(Mootz, et al., 2002).  For the production of surfactins, the srfA operon can be broken 
down into the genes srfA-A, srfA-B and srfA-C to make the groups of modules as shown 
below in figure 1.  The srfA-A gene contains the nucleotides to make the first three 
enzyme modules and so forth (Lee, et al., 2007). 
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Figure 1.  The srfA Operon and Genes for Seven Modules. 
 
 
  
 
 
 
Lipoinitiation and Adenylation 
 
  Two theories abound for the lipidation of monomers both of which involve fatty 
acyl-CoA ligase (FACL) (Baltz et al., 2005).  One proposed scheme involves adenylation 
of the fatty acid from primary metabolism followed by conversion into the energy-rich 
CoA thioester.  This CoA thioester is then recruited to the donor site of the starter 
condensation domain where it is attacked by the nucleophilic nitrogen of the tethered 
amino acid as shown below in figure 2.  Amino acids are not incorporated directly into 
the growing peptide chain.  They must first be adenylated in the adenylation domain to 
impart reactivity toward the terminal sulfhydryl of 4’-phosphopantetheine (4’-PP) 
(Kleinkauf, 1995, Stachelhaus, et al., 1998).  
 
 
 
 
 
 
 
srfA Operon 
srfA-A srfA-B srfA-C 
Modules 1,2 & 3 Modules 4,5 & 6 Module 7 
E-L-dL V-D-dL L 
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Figure 2. Lipoinitiation and Adenylation.  In this proposed mechanism, fatty acids are first 
adenylated and then recruited to the donor site as acyl CoA donor substrates.  Nascent monomers 
attached to the 4’-PP arm can then enter the acceptor site where they can condense with the 
thioester to form the lipidated monomer.  Grünewald and Marahiel, Handbook of Biologically 
Active Peptides, 2013.  
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Peptide Elongation 
 The importance of the peptidyl carrier protein (PCP) or thiolation domain of the 
multi-enzyme complex has led to the “PCP-centered view” of lipopeptide biosynthesis.  
Nascent amino acids become tethered to the peptidyl carrier protein via the highly 
flexible 4’-PP cofactor.  The transfer of the 4’-PP cofactor to the peptidyl carrier protein 
occurs due to the presence of the sfp gene which encodes for the enzyme 
phosphopantetheinyl transferase (Lee, et al., 2007, Galli, et al. 1994).  This cofactor is 
posttranslationally attached to the PCP via a highly conserved serine residue to give rise 
to the thiolation domain (Grünewald 2013).   In this way, monomers are added to each 
module in an almost assembly-line fashion as shown in figure 3 below.   
 In addition to condensation, adenylation and thiolation; epimerization, N-
methylation and heterocyclization can occur (Kleinkauf, 1990).  In the case of 
epimerization, it has been recognized that formation of d building blocks impart 
resistance to proteases which are l specific (Grünewald, 2013).  The incorporation of a d 
stereoisomer directly has been known to occur but most often proceeds through 
epimerization (Silverman, 2002). 
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Figure 3.  Peptide Elongation.  Each reactive monomer is tethered to the condensation domain 
via the 4’-PP (wavy line).  
 
 
Termination and Cyclization     
  According to the Norine database, macrolactonization and macrolactamization  
account for 64% of all nonribosomally produced peptides.  This final step serves to 
rigidify the lipopeptide and constrain it into a biologically active form.  Research 
performed by Hoefler and colleagues suggests that the cyclized form of surfactin is 
indeed necessary for activity against the bacterial pathogen Streptomyces sp. Mg1 
(Hoefler et al., 2012).  Similarly, the cyclized form of fengycins was shown to be 
absolutely necessary for antifungal activity (Tosco et al., 2015).  In order for cyclization 
to occur, the thioester of the most downstream PCP domain is attacked by the hydroxyl of  
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serine in a catalytic triad of histidine and aspartate.  The resulting peptidyl-O-TE oxoester 
can then undergo attack by an amine or hydroxyl group to complete cyclization and 
release from the thioesterase domain (Grünewald, 2013).   
The exact mechanism by which surfactins are excreted is unknown.  It is believed 
that excretion occurs via diffusion since a transporter has yet to be identified.  Gram 
positive lantibiotic producers such as Bacillus subtilis have ways to obviate the action of 
their own products.  For the lantibiotics, this is accomplished through ATP binding 
cassette (ABC) transporters which move the lantibiotic to the extracellular space.  For 
surfactins, it is believed this is accomplished via the YerP gene.  This gene is an example 
of a RND (resistance, nodulation and cell division) family of multidrug efflux pumps in 
Gram positive bacteria (Stein et al., 2005). 
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CHAPTER III 
  
LIPOPEPTIDE FUNCTION 
 
Regulation of Surfactin Production 
 
The regulation of surfactin biosynthesis is coordinated through signals such as 
 
 starvation, sporulation, genetic competence development and production of degradative 
 
enzymes (Losick et al., 1986; Marahiel et al., 1993).  The depletion of one or more 
 
nutrients such as glucose can induce starvation.  When this occurs some cells can begin 
 
sporulation which releases DNA into the extracellular matrix.  This uptake of exogenous 
 
DNA is termed genetic competence.  Mutational analysis has shown that a gene termed 
 
comS is embedded within the srfA-B gene and is dependent upon the srfA promoter for 
 
expression.  This comS gene is required for genetic competence (Solomon, et al., 1996). 
   
Competence is also dependent upon the buildup of an extracellular peptide encoded by 
 
the comX gene (D’Souza et al., 1994).  In this way, srfA expression is controlled through 
a quorum sensing mechanism.  ComX binds at the cellular membrane to a membrane 
bound histidine kinase comP and the response regulator comA.  ComA 
autophosphorylates and then transfers its phosphate to comA which initiates transcription 
of the srfA operon (Sullivan, 1998; Magnuson, 1994).  
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Quorum Response 
 
 Surfactin production is initiated when cell density reaches sufficient quantities to 
produce the small signal peptide from comX.  The two component regulatory response 
which follows the binding of the comX peptide is a common theme for Gram positive 
bacteria.  Experiments to monitor surfactin production in the 203R strain showed that 
lipopeptide formation was slightly delayed but followed exponential phase of growth 
starting at an optical density of 0.7 as shown in figure 4 below. 
 
Figure 4.  Surfactin Production over 24 Hours.   
 
 
 
 
 
 
 
 
 
 
 
 
For Gram negative bacteria, quorum sensing induces a N-acylhomoserine lactone (an 
autoinducer) to bind to a transcriptional activator to control expression of genes.  Quorum 
sensing is common to bacteria and can control the production of virulence factors,  
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biosurfactant production, secondary metabolites, transfer of genetic material as well as 
swarming (Sullivan, 1998). 
  
Swarming and Motility 
 Motility in bacteria can be used to avoid antimicrobial substances as well as gain 
access to nutrients.  There are three recognized forms of movement for Bacillus subtilis: 
sliding, swimming and swarming.  Hyperflagellation of vegetative cells is the most 
recognized stage of differentiation for B. subtilis and is necessary for swarming.  In the 
planktonic state, B. subtilis is able to swim as single cells through aqueous medium. If the 
medium is sufficiently viscous to support B. subtilis, hyperflagellated cells align closely 
along their long axis and join to form rafts and move across the surface via swarming 
(Fraser, et al., 1999; Liu, et al., 2018).  Experiments by Kinsinger have shown the 
necessity of surfactin and K
+
 ion in motility of B. subtilis.  In this case, cells from the 
leading edge of dendritic growth did not show the presence of flagella when Ryu stained 
(Heimbrook, et al., 1989) and the mechanism of movement was determined as sliding 
instead of swarming (Kinsinger, et al., 2003).  
 
Other Functions 
 
As previously mentioned, the antiviral, antitumor, hemolytic and antibacterial 
properties of surfactin are believed to stem from its ability to perturb lipid membranes 
and viral envelopes.  Particularly in Gram positive organisms, where the cell wall is 
simpler, this is perceived as a defense mechanism. The disruption of lipid membranes, as 
determined via POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) 
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liposomes, was found to begin at a surfactin concentration of 2 µM (Heerklotz and 
Seelig, 2007).  
Furthermore, the very nature of lipopeptides gives them an inherent ability to 
increase the surface area of hydrophobic water-insoluble growth substrates.  In this way 
the bioavailability of nutrients is increased.  Finally, the connection between attachment 
and detachment from surfaces and production of surfactin cannot be underestimated 
(Rosenberg and Ron, 1999).  B. subtilis biofilm formation is dependent on the early 
sporulation gene product SpoOA and transcription factors σ
H
 and AbrB (Stein, 2005;  
Marahiel, 1993; Hamon and Lazazzera, 2001).  In 2004 it was shown that colonization 
around plant roots and the subsequent biofilm formation were connected with surfactin 
production (Bais et al., 2004)
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CHAPTER IV  
METHODS 
 
Discovery of the Organism 
 
In order to find superior surfactin producing strains without using genetic 
modification, soil samples were taken from areas prone to oil degraders (Vater et al., 
2002). Samples were heat treated in a sand bath at 80°C in order to kill vegetative cells 
and leave only the spore forming Bacilli.  Gram sized aliquots were taken and cultured in 
media enriched with yeast extract and optimized for growth of Bacillus subtilis via the 
Taguchi method (Wei et al., 2007).  Aliquots of seed culture were transferred to fresh 
broth to reduce the soil content for spread plating.  Upon regrowth, samples were serial 
diluted on agar containing 5% sheeps blood.  Surfactin producing strains were 
determined by measuring radii of β-hemolysis (Mulligan et al., 1989) as the ones shown 
in figure 5 below.  
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Figure 5.  Isolates from Various Locations in Buck Swamp, Goldsboro, NC. 
 
 
 
 
Promising colonies were subjected to 16S-rRNA sequencing for identification (Pyoung Il 
et al., 2010).  
Solvent Systems for UPLC and Sample Preparation 
 
The dissolution of the cyclic heptapeptide surfactin presented many difficulties.  In 
 
order to minimize sample matrix effects, the optimal sample solvent is one that is 
 
identical to the mobile phase, however this solvent fails to dissolve surfactin efficiently. 
 
A solvent system was designed that would dissolve purified surfactin and yet mimic the 
 
culture broth matrix.  This system was found to be 95% ethanol containing 5% culture 
 
matrix containing only the sodium and potassium phosphates diluted to 25% original 
concentration.  For the method validation, a 500 ppm stock solution of surfactin standard 
(Sigma-Aldrich) was made and diluted arithmetically in half to a concentration of 0.9735 
ppb.  Samples were ran from lowest to highest concentration with triple injections and a 
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wash between each concentration to prevent sample carryover.  A total of 4 calibration 
curves were performed on different days and averaged to a final curve. Mass tolerance 
for the selected ion chromatograms of each parent ion was set to ±5 ppm. The best 
chromatography was found utilizing an Accucore C30 column, 150 X 2.1 mm, 2.6µm 
particles held at 30ºC.  Solvent conditions for the UPLC are given below in Table 2.  
 
Table 2.  Reversed Phase UPLC Ramp Program. 
A: H2O with 0.1% Formic Acid 
B: ACN with 0.1% Formic Acid 
Time Flow %A %B 
0.0 0.3 40 60 
0.5 0.3 40 60 
2.0 0.3 20 80 
10.0 0.3 11 89 
10.5 0.3 0 100 
10.75 0.3 0 100 
11.0 0.3 40 60 
 
The preparation of samples was accomplished by dilution in ethanol and spin filtered to 
an anticipated concentration within the linear dynamic range.  
  
Electrospray Ionization Conditions 
 
High Resolution Mass spectrometry was accomplished via a Thermo LTQ Mass 
Spectrometer utilizing Orbitrap technology.  Mass calibration was achieved using a 
positive ion calibration mix containing caffeine, the small peptide MRFA and Ultramark 
1621 at a B ring distance from the capillary transfer tube.  Acidic conditions were chosen 
in our reversed phase method to facilitate retention within the column. The sheath gas  
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was heated for introduction of ions from the source at a distance C from the capillary  
transfer tube.  Values for the tune file are listed in Table 3 below. 
 
 
Table 3.  Tune File Conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surfactin Production in Various Strains 
 
 In order to further establish the 203R strain as a prominent producer of surfactins,  
 
multiple strains of Bacillus subtilis: 21332, NRRL B-558, NRRL NRS-1270, NRRL B- 
 
3383, 168 and 6633, and one Pseudomonas aeruginosa strain 17934 were cultured in the  
 
same way.  These cultures were grown from cryostock in identical media, temperature 
 
and aeration.  Samples were cultured for 24 hours and frozen until evaluated for  
 
lipopeptide content. 
Capillary Temp. 350°C 
Sheath Gas Flow 35 
Aux Gas Flow 30 
Source Voltage 3.70 kV 
Capillary Voltage 44.00 V 
Tube Lens 135.00 V 
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CHAPTER V 
RESULTS AND DISCUSSION 
 
UPLC Separation 
  
 Several UPLC columns were used to improve the resolution of surfactin homologs 
and isoforms: Waters Acquity UPLC BEH Amide, 130Å, 1.7 μm, 2.1 X 150 mm (data not 
shown), Agilent Zorbax Bonus RP C18 Amide, 2.1 X 150 mm, 1.8 µm and Waters Acquity 
BEH C18, 2.1 X 150 mm, 1.7 µm.  Although the amide columns had higher anticipation to 
separate the cyclic lipopeptides of interest, the presence of the lipopeptide chain appeared 
to dominate the separation mechanism and thus a reverse phase separation mode was 
used.  Methanol failed to elute the surfactins from the Zorbax Bonus RP Amide phase and 
thus ethanol was chosen for the separation.  A second reason for the use of ethanol was 
its’ lower viscosity than isopropyl alcohol and thus reduced back pressure.  Likewise, 
analytes were separated under acidic conditions and acetonitrile was found to yield a 
superior separation over methanol and ethanol as shown in figure 6 below.   
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Figure 6.  UPLC Column Optimization.  A:  Chromatogram obtained using Zorbax Bonus RP, 
C18 amide and ethanol solvent ramp.  B: Chromatogram obtained using Waters Acquity BEH C18 
phase and acetonitrile solvent ramp.   
 
 
 
 
Distinguishing between the A and C isoforms of surfactins presented a challenge. 
Since these two isoforms vary only at the seventh amino acid residues, which are leucine 
and isoleucine, they are isobaric.  Surfactin B varies with a valine residue at the seventh 
position and is more easily separated on the basis of its hydrophobic chain length owing 
to the reverse phase conditions.  We were able to obtain near baseline resolution for the A 
and C isoforms through C14.  Figure 7 below shows the total ion chromatogram. 
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Figure 7. Base Peak of Total Ion Chromatogram. TIC obtained using Accucore C30 phase and 
acidic water/acetonitrile solvent ramp: Peak A: C12-Isoform A, B: C12-Isoform C: C13-Isoform A, 
D: C13-Isoform C, E: C14-Isoform A, F: C14-Isoform C, G: C14-Isoform B, H: C15-Isoform A, I: 
C15-Isoform C, J: C15-Isoform B, K: C16-Isoform B. 
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Masses and Fragmentation 
 
The use of sodium and potassium phosphates in the culture matrix created both 
adducts in the source and must be taken into consideration for the quantification of total 
surfactins.  Table 4 below lists the ions present and upon closer examination shows a 
repeating pattern of masses for the valine isoform with the addition of a methylene group 
for the next higher homolog.  
 
Table 4. Ions used in Quantification of Total Surfactins. 
 
 
 
 
  To distinguish the valine isoform from the surfactins A and C, fragmentation of 
the precursor masses was performed.  The difference of a single methylene unit in valine 
created a fragment with m/z 671.86 versus cleavage at the same positions for the surfactin 
A and C isoforms which yielded m/z 685.88 (Pecci et al., 2010).  Figure 8 shows the 
994.6414 precursor ions and their resulting MS-MS spectra for each retention time.  
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Figure 8. Extracted Ion Chromatogram.  The 994.6414 precursor ion and resulting 
fragmentation. A:  All ions of m/z 994.6414 eluting over the given time range.  B:    
Fragmentation pattern of the ions at retension time 7.80 minutes.  C:  Fragmentation pattern  
of the ions at retension time 8.81 minutes.    
 
 
 
 
Method Validation for Surfactin Quantification 
 
An analysis of the log-log curves for each calibration curve revealed that linearity 
deviated below 0.1246 ppm and above 250 ppm.  The final averaged calibration curve is 
shown in Figure 9. 
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Figure 9.  Average of Four Calibration Curves.  
 
 
 
 
Applying linear regression analysis gave a correlation coefficient of 0.995 as 
shown in Table 5 below. 
 
 
 
 
 
 
 
 
y = 8E+07x + 6E+08 
R² = 0.9946 
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Table 5. Linear Regression Parameters. 
 
Validation Parameter Result 
Correlation coefficient 0.995 
Standard error 6.58 x 108 
y-intercept 6.20 x 108 ± 4.5 x 108 
Slope of regression line 7.94 x 107 ± 3.4 x 106 
Number of data points 5 
Range 15.9 - 255 ppm 
Limit of Detection (LOD)a 8.0 ppm 
Limit of Quantification (LOQ)b 16 ppm 
 
a. LOD defined as the lowest concentration which gave a total ion signal three times greater  
than the noise. 
b. LOQ defined as the lowest concentration which gave a residual of 15% or less.  
  
 
When determining residuals, the low concentrations extended from 15 to 2100%.  All 
concentrations below 15% residuals were truncated (Junio, et al., 2013) yielding a 
calibration curve with a range through one order of magnitude.  This small linear 
dynamic range is likely due to further saturation at the upper limit and poor repeatability 
for the ion areas at low concentrations.  Table 6 shows the accuracy and precision for the 
validated method. 
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Table 6. Accuracy and Precision. 
   
Theoretical 
Conc. (ppm) 
Measured 
Conc. (ppm) 
Residualsa 
(%) 
Repeatabilityb 
(%) 
Intermediate 
Precisionc (%) 
15.95 13.49 -15 5.7 2.9 
31.9 22.32 3.4 12 3.1 
63.8 73.80 16 10 2.0 
127.6 137.1 7.5 0.23 3.2 
255.2 248.1 -2.8 4.4 0.84 
 
a.  Residuals were calculated as follows: (measured concentration-theoretical concentration)/ 
     theoretical concentration x 100. 
b.  Repeatability is expressed as the % relative standard deviation for back calculated surfactin 
     concentrations determined by triplicate analyses conducted on a single day. 
c.  Intermediate precision is expressed as the % relative standard deviation of the four back- 
     calculated surfactin concentrations (each an average of triplicate measurements determined  
     on four separate days).  
 
Production of Surfactins in Various Strains 
 
 Many strains of B. subtilis and other species contain the genes for antibiotic 
production. We sought to further investigate multiple B. subtilis strains from the USDA 
as well as one P. aeruginosa strain for surfactin production.  B. subtilis 168 was used as a 
potential negative control because of its years of laboratory cultivation and use as a 
model Bacillus strain.  This original Marburg 168 strain was reportedly exposed to X-
rays in the 1940s and does not produce lipopeptides or polyketides (Burkholder and 
Giles, 1947; Stein, T. 2005; Kinsinger, R. 2003).  It has also been documented that a 
frameshift mutation in the sfp gene of strain 168 resulted in an inactive form of PPan 
transferase and thus the 4’-PP arm cannot be transferred to the thiolation domain (Mootz 
et al, 2001).  Results for the various strains are shown below in figure 10. 
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Figure 10.  Surfactin Production across Multiple Strains of B. subtilis. 
  
 
 
 
Although Pseudomonas aeruginosa 17934, NRRL B-558 and B. subtilis 168 did not  
produce surfactin above the limit of quantification (16 ppm), ions corresponding to the 
 
masses and retension times of surfactin were detected in the culture media for these 
organisms.  Their total area sums remained below the limit of detection, as defined by the 
method validation, and even several orders of magnitude below the y-intercept value for 
the calibration curve.  Consistent with published literature, the previous model strain 
ATCC 21332, produced detectable surfactins of 425 ppm (Mohammadipour et al., 2009). 
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 CHAPTER VI 
 
CONCLUSION 
 
 
 The solubility of purified surfactin is very limited when compared to being 
synthesized by the organism and excreted in situ into the culture broth matrix.  This 
limited solubility makes it impossible to dissolve the analytical standard, which was 
purified by acid precipitation, in the starting mobile phase or culture matrix.  To 
ameliorate this, a suitable solvent system was created to mimic the ions found in the 
actual culture matrix.  Since actual samples from a batch process would contain a 
disproportionate amount of sodium and potassium ions compared to the calibration 
standards, all possible ions were summed in the calibration and culture samples to give an 
equal weighting to both.      
 Prior literature suggested using reversed phase chromatography utilizing C18 
phases for separation of surfactins.  Our method involving an Accucore C30 column 
improved resolution of the surfactin envelope particularly throughout the C14 chain 
lengths.  When coupling the UPLC retention times with the fragmentation pattern of the 
precursor ions, it was possible to discriminate the A and C isoforms from the surfactin B 
isoform.  This gave an added layer of identification to surfactin peaks and helped prevent 
misidentification if other identical masses are present.   
 Four calibration curves collected on different days with each concentration in 
triplicate gave good repeatability, within the linear dynamic range, with a correlation 
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coefficient of 0.995.  Although breakdown of linearity was clearly identified from the 
log-log transformations, other factors obligated the linear dynamic range to be further 
truncated.  Upon analysis of the % residuals it became apparent that at concentrations less 
than 16 ppm quantification was not possible.  Even though surfactins could easily be 
detected at concentrations of 2 ppm and less, our chosen definition for LOD of signal to 
noise ratio of 3:1 meant a LOD of 8 ppm was set. 
 The 203R strain of Bacillus subtilis was originally screened for surfactin 
production based on clearing zones of β-hemolysis.  Using mass spectrometry enabled a 
quantitative way of further establishing this strain as a superior producer of surfactins as 
compared to other B. subtilis strains evaluated.  Although UPLC coupled to HRMS is a 
far superior method for quantifying surfactins than gravimetric or surface tension 
methods, the inherent similarity between different classes of biosurfactants can produce 
situations of coelution.  In our case, the iturins also contain the same range of fatty acyl 
chains and a seven-membered cyclic heptapeptide but are joined through lactam 
cyclization.  Since the mode of UPLC separation was reversed phase, the iturins coeluted 
within the surfactin envelope.  The iturin class of lipopeptides produced several ions of 
similar mass but not within the 5ppm mass tolerance set for the surfactin quantification.  
For this reason, the HRMS application coupled with an improved separation before the 
MS interface allowed differentiation between surfactins and iturins as well as the 
surfactin valine isoform from the A and C forms. 
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                                                           APPENDIX A 
  
SUPPLEMENTARY DATA 
 
 
               Figure 11. Glucose Depletion throughout Culture. 
 
 
